RAPID HEMATOPOIETIC RECONSTITUTION FOLLOWING 3 CYCLES OF HIGH-DOSE CHEMOTHERAPY WITH FILGRASTIM (G-CSF)-MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) AND FILGRASTIM IN PATIENTS WITH HIGH-RISK BREAST-CANCER

被引：0
|
作者：
BASSER, R
TO, B
GREEN, M
SZER, J
BAYLY, J
DUGGAN, G
BEGLEY, G
DYSON, P
FOX, R
COLLINS, J
RUSSELL, I
MAHER, D
CEBON, J
MARTY, J
JUTTNER, C
DZIEM, G
HOFFMAN, E
SHERIDAN, W
机构：
[1] LUDWIG INST MELBOURNE,TUMOR BIOL BRANCH,MELBOURNE,AUSTRALIA
[2] ROYAL MELBOURNE HOSP,HANSON CTR CANC RES,PARKVILLE,VIC 3050,AUSTRALIA
[3] ALFRED HOSP,WALTER & ELIZA HALL INST,PRAHRAN,VIC 3181,AUSTRALIA
[4] AMGEN INC,THOUSAND OAKS,CA
来源：
BLOOD | 1993年 / 82卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A233 / A233
页数：1
相关论文
共 50 条
  • [1] EFFECT OF PERIPHERAL-BLOOD PROGENITOR CELLS MOBILIZED BY FILGRASTIM (G-CSF) ON PLATELET RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY
    SHERIDAN, WP
    BEGLEY, CG
    JUTTNER, CA
    SZER, J
    TO, LB
    MAHER, D
    MCGRATH, KM
    MORSTYN, G
    FOX, RM
    LANCET, 1992, 339 (8794): : 640 - 644
  • [2] EFFECT OF PERIPHERAL-BLOOD PROGENITOR CELLS MOBILIZED BY FILGRASTIM (G-CSF) ON PLATELET RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY
    GRIGG, A
    BEGLEY, CG
    JUTTNER, CA
    SZER, J
    TO, LB
    MAHER, D
    MCGRATH, KM
    MORSTYN, G
    FOX, RM
    SHERIDAN, WP
    BONE MARROW TRANSPLANTATION, 1993, 11 : 23 - 29
  • [3] Filgrastim versus CAF chemotherapy and filgrastim as peripheral blood progenitor cells (PBPC) mobilisation for breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic rescue
    Kusminsky, G
    Kohan, A
    Niborski, R
    Zylberman, M
    Dictar, M
    Chacon, R
    Avalos, JCS
    BLOOD, 1995, 86 (10) : 3932 - 3932
  • [4] Adjuvant treatment of high-risk breast cancer using multicycle high-dose chemotherapy and filgrastim-mobilized peripheral blood progenitor cells
    Basser, RL
    To, LB
    Begley, CG
    Juttner, CA
    Maher, DW
    Szer, J
    Cebon, J
    Collins, JP
    Russell, I
    Olver, I
    Gill, PG
    Fox, RM
    Sheridan, WP
    Green, MD
    CLINICAL CANCER RESEARCH, 1995, 1 (07) : 715 - 721
  • [5] TANDEM CYCLES OF HIGH-DOSE CHEMOTHERAPY (HDC) SUPPORTED WITH G-CSF PRIMED PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC)
    MEISENBERG, B
    MILLER, W
    MCMILLAN, R
    BLOOD, 1994, 84 (10) : A715 - A715
  • [6] MULTIPLE HIGH-DOSE CHEMOTHERAPY CYCLES SUPPORTED BY PERIPHERAL-BLOOD PROGENITOR CELLS AND G-CSF
    CHAO, NJ
    LONG, GD
    NEGRIN, RS
    KUZNIERZGLAS, C
    BLUME, KG
    BLOOD, 1993, 82 (10) : A349 - A349
  • [7] A phase I/II study of multicycle high-dose chemotherapy supported by filgrastim-mobilized peripheral blood progenitor cells (PBPC) for patients with advanced or high-risk cancer.
    Mason, J
    Brehm, T
    Miller, W
    McMillan, R
    Meisenberg, B
    BLOOD, 1998, 92 (10) : 369B - 369B
  • [8] PHASE-II STUDY OF AUTOLOGOUS FILGRASTIM (G-CSF)-MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS TO RESTORE HEMATOPOIESIS AFTER HIGH-DOSE CHEMOTHERAPY FOR LYMPHOID MALIGNANCIES
    SHERIDAN, WP
    BEGLEY, CG
    TO, LB
    GRIGG, A
    SZER, J
    MAHER, D
    GREEN, MD
    ROWLINGS, PA
    MCGRATH, KM
    CEBON, J
    DYSON, P
    WATSON, D
    BAYLY, J
    DELUCA, E
    TOMITA, D
    HOFFMAN, E
    MORSTYN, G
    JUTTNER, CA
    FOX, RM
    BONE MARROW TRANSPLANTATION, 1994, 14 (01) : 105 - 111
  • [9] THE ENGRAFTMENT CAPACITY OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) MOBILIZED WITH CHEMOTHERAPY +/- G-CSF
    PETTENGELL, R
    DEMUYNCK, H
    TESTA, NG
    DEXTER, TM
    INTERNATIONAL JOURNAL OF CELL CLONING, 1992, 10 : 59 - 61
  • [10] AUTOLOGOUS TRANSPLANTATION OF PERIPHERAL-BLOOD PROGENITOR CELLS MOBILIZED BY CHEMOTHERAPY WITH OR WITHOUT G-CSF (FILGRASTIM) IN RESISTANT LYMPHOPROLIFERATIVE DISEASES - ENHANCED HEMATOPOIETIC RECOVERY WITH FILGRASTIM PRIMED PROGENITORS
    SICA, S
    SALUTARI, P
    DIMARIO, A
    RUTELLA, S
    ORTULABARBERA, E
    STORTI, S
    DESTEFANO, V
    MENICHELLA, G
    PIERELLI, L
    ZINI, G
    LEONE, G
    HAEMATOLOGICA, 1993, 78 (06) : 383 - 388
12345